ID: ALA191071

Max Phase: Preclinical

Molecular Formula: C17H17BrN4O3

Molecular Weight: 405.25

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cc(Cc2cnc(N)nc2N)cc(C#CCCC(=O)O)c1Br

Standard InChI:  InChI=1S/C17H17BrN4O3/c1-25-13-8-10(7-12-9-21-17(20)22-16(12)19)6-11(15(13)18)4-2-3-5-14(23)24/h6,8-9H,3,5,7H2,1H3,(H,23,24)(H4,19,20,21,22)

Standard InChI Key:  DWQGRIVGUVJVRF-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 405.25

Molecular Weight (Monoisotopic): 404.0484

AlogP: 2.22

#Rotatable Bonds: 5

Polar Surface Area: 124.35

Molecular Species: ACID

HBA: 6

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 2.97

CX Basic pKa: 7.17

CX LogP: 1.21

CX LogD: 0.79

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.65

Np Likeness Score: 0.08

References

1. Chan DC, Fu H, Forsch RA, Queener SF, Rosowsky A..  (2005)  Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.,  48  (13): [PMID:15974594] [10.1021/jm0581718]

Source

Source(1):

• Scientific Literature